COSMAX USA CORPORATION has acquired Keminova Italiana S.B. srl for an undisclosed amount. The acquisition sees the US-based entity take full ownership of the Italian company, known for its extensive experience in cosmetic manufacturing. Keminova, established in 1985, has grown significantly over nearly four decades, evolving from a small manufacturer into a dynamic Italian leader in skincare product formulation and production, including medical devices.
Keminova Italiana S.B. srl has built a reputation for offering a comprehensive and reliable service to its clients, guiding them through every stage of product development from initial concept to final production. The company emphasizes innovation through simplification, delivering proven results backed by its professional expertise. Keminova is recognized for its technical excellence and, since 2022, has operated as a Società Benefit, reflecting a commitment to both profit and positive societal impact.
This strategic acquisition is expected to significantly enhance COSMAX USA CORPORATION's global footprint and capabilities. By integrating Keminova's specialized formulation and manufacturing expertise, particularly in the European market, COSMAX USA aims to expand its product portfolio in skincare and medical devices. The move provides COSMAX USA with established production capacity and a strong technical foundation, facilitating broader market access and diversified offerings.
The combination of COSMAX USA CORPORATION's market presence and Keminova's deep technical knowledge and manufacturing prowess is anticipated to create a more robust and competitive entity. The unified operation is poised to leverage synergies in research and development, production efficiency, and client service, strengthening its position within the global beauty and healthcare industries.